HEADER TRANSCRIPTION 05-JUN-07 2Q70 TITLE ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN COMPLXED TO A BENZOPYRAN TITLE 2 LIGAND COMPND MOL_ID: 1; COMPND 2 MOLECULE: ESTROGEN RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND-BINDING DOMAIN (RESIDUES 304-551); COMPND 5 SYNONYM: ER, ESTRADIOL RECEPTOR, ER-ALPHA; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ESR1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TRANSCRIPTION FACTOR, ESTROGEN RECEPTOR, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR Y.WANG REVDAT 4 20-OCT-21 2Q70 1 REMARK SEQADV REVDAT 3 24-FEB-09 2Q70 1 VERSN REVDAT 2 30-OCT-07 2Q70 1 JRNL REVDAT 1 07-AUG-07 2Q70 0 JRNL AUTH T.I.RICHARDSON,J.A.DODGE,G.L.DURST,L.A.PFEIFER,J.SHAH, JRNL AUTH 2 Y.WANG,J.D.DURBIN,V.KRISHNAN,B.H.NORMAN JRNL TITL BENZOPYRANS AS SELECTIVE ESTROGEN RECEPTOR BETA AGONISTS JRNL TITL 2 (SERBAS). PART 3: SYNTHESIS OF CYCLOPENTANONE AND JRNL TITL 3 CYCLOHEXANONE INTERMEDIATES FOR C-RING MODIFICATION. JRNL REF BIOORG.MED.CHEM.LETT. V. 17 4824 2007 JRNL REFN ISSN 0960-894X JRNL PMID 17614275 JRNL DOI 10.1016/J.BMCL.2007.06.052 REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2005 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.93 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 2495925.740 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 94.3 REMARK 3 NUMBER OF REFLECTIONS : 37307 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.260 REMARK 3 R VALUE (WORKING SET) : 0.260 REMARK 3 FREE R VALUE : 0.303 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.800 REMARK 3 FREE R VALUE TEST SET COUNT : 1036 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.009 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.95 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.07 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 74.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4702 REMARK 3 BIN R VALUE (WORKING SET) : 0.3620 REMARK 3 BIN FREE R VALUE : 0.3660 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 2.90 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 138 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.031 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3551 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 46 REMARK 3 SOLVENT ATOMS : 44 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 29.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 46.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 8.10000 REMARK 3 B22 (A**2) : 6.79000 REMARK 3 B33 (A**2) : -14.88000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.31 REMARK 3 ESD FROM SIGMAA (A) : 0.35 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.35 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.35 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 0.900 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 20.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.670 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.450 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.320 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.270 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.380 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.38 REMARK 3 BSOL : 53.03 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.P REMARK 3 PARAMETER FILE 3 : WATER_REP.PAR REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : LIG.PAR REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2Q70 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-JUL-07. REMARK 100 THE DEPOSITION ID IS D_1000043228. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37308 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.950 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.2 REMARK 200 DATA REDUNDANCY : 5.700 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 24.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.02 REMARK 200 COMPLETENESS FOR SHELL (%) : 67.1 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.51700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.040 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.76 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.35 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M TRIS, 0.2M MAGNESIUM CHLORIDE, REMARK 280 20% PEG 4000, 10% ETHYLENE GLYCOL, PH 8.0, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 87.07800 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 87.07800 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 31.27900 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 48.94000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 31.27900 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 48.94000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 87.07800 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 31.27900 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 48.94000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 87.07800 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 31.27900 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 48.94000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN A 304 REMARK 465 SER A 305 REMARK 465 THR A 334 REMARK 465 ARG A 335 REMARK 465 PRO A 336 REMARK 465 PHE A 337 REMARK 465 LYS A 529 REMARK 465 SER A 530 REMARK 465 LYS A 531 REMARK 465 ASN A 532 REMARK 465 VAL A 533 REMARK 465 HIS A 550 REMARK 465 ALA A 551 REMARK 465 ASN B 304 REMARK 465 SER B 305 REMARK 465 TYR B 331 REMARK 465 ASP B 332 REMARK 465 PRO B 333 REMARK 465 THR B 334 REMARK 465 ARG B 335 REMARK 465 PRO B 336 REMARK 465 PHE B 337 REMARK 465 SER B 338 REMARK 465 GLU B 339 REMARK 465 ALA B 340 REMARK 465 LEU B 462 REMARK 465 SER B 463 REMARK 465 LYS B 529 REMARK 465 SER B 530 REMARK 465 LYS B 531 REMARK 465 ASN B 532 REMARK 465 VAL B 533 REMARK 465 VAL B 534 REMARK 465 PRO B 535 REMARK 465 LEU B 536 REMARK 465 TYR B 537 REMARK 465 ASP B 538 REMARK 465 LEU B 539 REMARK 465 LEU B 540 REMARK 465 LEU B 541 REMARK 465 GLU B 542 REMARK 465 MET B 543 REMARK 465 LEU B 544 REMARK 465 ASP B 545 REMARK 465 ALA B 546 REMARK 465 HIS B 547 REMARK 465 ARG B 548 REMARK 465 LEU B 549 REMARK 465 HIS B 550 REMARK 465 ALA B 551 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A 338 OG REMARK 470 GLU A 339 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 419 116.69 -37.13 REMARK 500 LEU A 462 -90.86 -40.35 REMARK 500 ARG A 548 61.72 -115.00 REMARK 500 GLU B 397 33.14 -83.64 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DC8 A 50 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DC8 B 51 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2I0J RELATED DB: PDB REMARK 900 RELATED ID: 2POG RELATED DB: PDB DBREF 2Q70 A 304 551 UNP P03372 ESR1_HUMAN 304 551 DBREF 2Q70 B 304 551 UNP P03372 ESR1_HUMAN 304 551 SEQADV 2Q70 SER A 381 UNP P03372 CYS 381 ENGINEERED MUTATION SEQADV 2Q70 SER A 417 UNP P03372 CYS 417 ENGINEERED MUTATION SEQADV 2Q70 SER A 530 UNP P03372 CYS 530 ENGINEERED MUTATION SEQADV 2Q70 SER B 381 UNP P03372 CYS 381 ENGINEERED MUTATION SEQADV 2Q70 SER B 417 UNP P03372 CYS 417 ENGINEERED MUTATION SEQADV 2Q70 SER B 530 UNP P03372 CYS 530 ENGINEERED MUTATION SEQRES 1 A 248 ASN SER LEU ALA LEU SER LEU THR ALA ASP GLN MET VAL SEQRES 2 A 248 SER ALA LEU LEU ASP ALA GLU PRO PRO ILE LEU TYR SER SEQRES 3 A 248 GLU TYR ASP PRO THR ARG PRO PHE SER GLU ALA SER MET SEQRES 4 A 248 MET GLY LEU LEU THR ASN LEU ALA ASP ARG GLU LEU VAL SEQRES 5 A 248 HIS MET ILE ASN TRP ALA LYS ARG VAL PRO GLY PHE VAL SEQRES 6 A 248 ASP LEU THR LEU HIS ASP GLN VAL HIS LEU LEU GLU SER SEQRES 7 A 248 ALA TRP LEU GLU ILE LEU MET ILE GLY LEU VAL TRP ARG SEQRES 8 A 248 SER MET GLU HIS PRO GLY LYS LEU LEU PHE ALA PRO ASN SEQRES 9 A 248 LEU LEU LEU ASP ARG ASN GLN GLY LYS SER VAL GLU GLY SEQRES 10 A 248 MET VAL GLU ILE PHE ASP MET LEU LEU ALA THR SER SER SEQRES 11 A 248 ARG PHE ARG MET MET ASN LEU GLN GLY GLU GLU PHE VAL SEQRES 12 A 248 CYS LEU LYS SER ILE ILE LEU LEU ASN SER GLY VAL TYR SEQRES 13 A 248 THR PHE LEU SER SER THR LEU LYS SER LEU GLU GLU LYS SEQRES 14 A 248 ASP HIS ILE HIS ARG VAL LEU ASP LYS ILE THR ASP THR SEQRES 15 A 248 LEU ILE HIS LEU MET ALA LYS ALA GLY LEU THR LEU GLN SEQRES 16 A 248 GLN GLN HIS GLN ARG LEU ALA GLN LEU LEU LEU ILE LEU SEQRES 17 A 248 SER HIS ILE ARG HIS MET SER ASN LYS GLY MET GLU HIS SEQRES 18 A 248 LEU TYR SER MET LYS SER LYS ASN VAL VAL PRO LEU TYR SEQRES 19 A 248 ASP LEU LEU LEU GLU MET LEU ASP ALA HIS ARG LEU HIS SEQRES 20 A 248 ALA SEQRES 1 B 248 ASN SER LEU ALA LEU SER LEU THR ALA ASP GLN MET VAL SEQRES 2 B 248 SER ALA LEU LEU ASP ALA GLU PRO PRO ILE LEU TYR SER SEQRES 3 B 248 GLU TYR ASP PRO THR ARG PRO PHE SER GLU ALA SER MET SEQRES 4 B 248 MET GLY LEU LEU THR ASN LEU ALA ASP ARG GLU LEU VAL SEQRES 5 B 248 HIS MET ILE ASN TRP ALA LYS ARG VAL PRO GLY PHE VAL SEQRES 6 B 248 ASP LEU THR LEU HIS ASP GLN VAL HIS LEU LEU GLU SER SEQRES 7 B 248 ALA TRP LEU GLU ILE LEU MET ILE GLY LEU VAL TRP ARG SEQRES 8 B 248 SER MET GLU HIS PRO GLY LYS LEU LEU PHE ALA PRO ASN SEQRES 9 B 248 LEU LEU LEU ASP ARG ASN GLN GLY LYS SER VAL GLU GLY SEQRES 10 B 248 MET VAL GLU ILE PHE ASP MET LEU LEU ALA THR SER SER SEQRES 11 B 248 ARG PHE ARG MET MET ASN LEU GLN GLY GLU GLU PHE VAL SEQRES 12 B 248 CYS LEU LYS SER ILE ILE LEU LEU ASN SER GLY VAL TYR SEQRES 13 B 248 THR PHE LEU SER SER THR LEU LYS SER LEU GLU GLU LYS SEQRES 14 B 248 ASP HIS ILE HIS ARG VAL LEU ASP LYS ILE THR ASP THR SEQRES 15 B 248 LEU ILE HIS LEU MET ALA LYS ALA GLY LEU THR LEU GLN SEQRES 16 B 248 GLN GLN HIS GLN ARG LEU ALA GLN LEU LEU LEU ILE LEU SEQRES 17 B 248 SER HIS ILE ARG HIS MET SER ASN LYS GLY MET GLU HIS SEQRES 18 B 248 LEU TYR SER MET LYS SER LYS ASN VAL VAL PRO LEU TYR SEQRES 19 B 248 ASP LEU LEU LEU GLU MET LEU ASP ALA HIS ARG LEU HIS SEQRES 20 B 248 ALA HET DC8 A 50 23 HET DC8 B 51 23 HETNAM DC8 (3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A, HETNAM 2 DC8 4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL FORMUL 3 DC8 2(C18 H16 F2 O3) FORMUL 5 HOH *44(H2 O) HELIX 1 1 LEU A 306 LEU A 310 5 5 HELIX 2 2 THR A 311 GLU A 323 1 13 HELIX 3 3 SER A 341 VAL A 364 1 24 HELIX 4 4 GLY A 366 LEU A 370 5 5 HELIX 5 5 THR A 371 SER A 395 1 25 HELIX 6 6 ARG A 412 VAL A 418 1 7 HELIX 7 7 MET A 421 ASN A 439 1 19 HELIX 8 8 GLN A 441 SER A 456 1 16 HELIX 9 9 GLY A 457 PHE A 461 5 5 HELIX 10 10 THR A 465 GLY A 494 1 30 HELIX 11 11 THR A 496 MET A 528 1 33 HELIX 12 12 PRO A 535 ASP A 545 1 11 HELIX 13 13 LEU B 306 LEU B 310 5 5 HELIX 14 14 THR B 311 GLU B 323 1 13 HELIX 15 15 SER B 341 VAL B 364 1 24 HELIX 16 16 GLY B 366 LEU B 370 5 5 HELIX 17 17 THR B 371 ARG B 394 1 24 HELIX 18 18 ARG B 412 LYS B 416 1 5 HELIX 19 19 MET B 421 ASN B 439 1 19 HELIX 20 20 GLN B 441 SER B 456 1 16 HELIX 21 21 GLY B 457 PHE B 461 5 5 HELIX 22 22 THR B 465 GLY B 494 1 30 HELIX 23 23 THR B 496 SER B 527 1 32 SHEET 1 A 2 LYS A 401 ALA A 405 0 SHEET 2 A 2 LEU A 408 ASP A 411 -1 O LEU A 410 N LEU A 402 SHEET 1 B 2 LYS B 401 ALA B 405 0 SHEET 2 B 2 LEU B 408 ASP B 411 -1 O LEU B 408 N ALA B 405 SITE 1 AC1 8 HOH A 3 GLU A 353 LEU A 384 LEU A 387 SITE 2 AC1 8 ARG A 394 PHE A 404 MET A 421 HIS A 524 SITE 1 AC2 9 HOH B 2 GLU B 353 LEU B 384 LEU B 387 SITE 2 AC2 9 ARG B 394 PHE B 404 ILE B 424 HIS B 524 SITE 3 AC2 9 LEU B 525 CRYST1 62.558 97.880 174.156 90.00 90.00 90.00 C 2 2 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015985 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010217 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005742 0.00000 MASTER 342 0 2 23 4 0 5 6 0 0 0 40 END